Cartrade Tech Limited Grants 60,000 ESOP Options to Eligible Employees
Cartrade Tech granted 60,000 ESOP options to eligible employees on October 28, 2025, under its ESOP 2021 (I) scheme, with a four-year vesting period and 0% discount.
While ESOP grants are positive for employees, the dilution impact of 60,000 options is relatively small for a listed company, making the overall market impact medium. It's a routine corporate action for employee compensation.
The grant of ESOPs is generally seen as a positive move for employee motivation, retention, and aligning employee interests with shareholder value creation.
Cartrade Tech Limited (CARTRADE) announced that its Nomination and Remuneration Committee (NRC) granted 60,000 (Sixty Thousand) Employee Stock Option Plan (ESOP) options to eligible employees under the ESOP 2021 (I) scheme on October 28, 2025. * Each ESOP option is convertible into one equity share of face value ₹10/-. * The ESOPs are granted at a 0% discount to the market price, calculated as the average closing price of the equity shares over the last thirty days preceding the grant date on the recognized stock exchange. * The vesting schedule is as follows: * 25% of options at the end of the 1st year from the Grant date. * 25% of options at the end of the 2nd year from the Grant date. * 25% of options at the end of the 3rd year from the Grant date. * 25% of options at the end of the 4th year from the Grant date. * All vested options can be exercised only two years after the date of grant and must be exercised within ten years from the date of grant. * The grant is in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
What to do with a filing like this
Cartrade Tech Limited filed this with the NSE as a statutory disclosure, categorised under other corporate actions. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Cartrade Tech Limited. Read the original for the full detail.